Leonard L. Mazur - Oct 10, 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Alexander M. Donaldson, by power of attorney
Stock symbol: CTXR
Transactions as of: Oct 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 10/12/2023, 04:15 PM
Previous filing: Nov 9, 2023
Next filing: Apr 5, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CTXR	Common Stock						10.3M	Oct 10, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Option to Purchase Common Stock	Award	$0	+550K		$0.00	550K	Oct 10, 2023	Common Stock	550K	$0.70	Direct	F10
holding	CTXR	Options to Purchase Common Stock						40K	Oct 10, 2023	Common Stock	40K	$3.45	Direct	F1
holding	CTXR	Options to Purchase Common Stock						220K	Oct 10, 2023	Common Stock	220K	$6.75	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						3.14M	Oct 10, 2023	Common Stock	3.14M	$1.15	Direct	F3
holding	CTXR	Options to Purchase Common Stock						150K	Oct 10, 2023	Common Stock	150K	$1.62	Direct	F4
holding	CTXR	Warrant to Purchase Common Stock						1.17M	Oct 10, 2023	Common Stock	1.17M	$1.42	Direct	F3
holding	CTXR	Warrant to Purchase Common Stock						2.23M	Oct 10, 2023	Common Stock	2.23M	$0.77	Direct	F3
holding	CTXR	Options to Purchase Common Stock						175K	Oct 10, 2023	Common Stock	175K	$0.67	Direct	F5
holding	CTXR	Options to Purchase Common Stock						200K	Oct 10, 2023	Common Stock	200K	$1.01	Direct	F6
holding	CTXR	Options to Purchase Common Stock						300K	Oct 10, 2023	Common Stock	300K	$2.00	Direct	F7
holding	CTXR	Option to Purchase Common Stock						650K	Oct 10, 2023	Common Stock	650K	$2.04	Direct	F8
holding	CTXR	Option to Purchase Common Stock						550K	Oct 10, 2023	Common Stock	550K	$1.25	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vested in full on September 13, 2020.
F2	The options vested in full on September 12, 2017
F3	The warrant is fully vested and exercisable immediately.
F4	The options vested in full on September 4, 2021.
F5	The options vested in full on October 8, 2022.
F6	The options vested in full on October 6, 2023.
F7	The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F8	The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F9	The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F10	The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.